Isagro and Arysta LifeScience sign long-term agreement
Isagro and Arysta LifeScience have entered into a 15-year license, development, distribution and supply agreement, giving Arysta LifeScience exclusive global rights to develop mixtures of tetraconazole (a proprietary fungicide of Isagro) and fluoxastrobin (a proprietary fungicide of Arysta LifeScience) for all agricultural markets.
Arysta LifeScience has also gained exclusive access to tetraconazole in the U.S. and Canada for the development of mixtures for foliar applications in certain small grains, pulses and canola, as well as the extension of its exclusive rights to tetraconazole in Japan.
Isagro will grant regulatory and registration access along with support for the development of the relevant mixtures; and Arysta LifeScience will purchase tetraconazole exclusively from Isagro.
“Arysta LifeScience is excited to be working with Isagro to develop proprietary mixtures of fluoxastrobin and tetraconazole,” said Wayne Hewett, CEO, Arysta LifeScience.
“Combinations of these two active ingredients will provide growers with new quality options to enhance yield through effective disease control and improved plant health.”
“This agreement confirms the validity of tetraconazole as a long-term, sustainable partner for the development of new, high performance fungicides,” said Giorgio Basile, Chairman and CEO, Isagro.
“With Arysta LifeScience’s new formulations we will extend the market platform of our key product, for which Isagro has a worldwide program of investments.”
Further terms of the agreement were not disclosed.
- Activists fighting Golden Rice even more in 2014
- U.S. GMO labeling foes triple spending in first half of this year
- Source shows half of GMO research is independent
- White House issues veto threat on bill to block WOTUS rule
- Stoller soybean research produces 214 bushels per acre
- USDA invites public comments on climate report